reports
Medadvisor Limited: 1 director
A director at Medadvisor Limited sold 6,846,955 shares at 0.180AUD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
MedAdvisor to Expand into Hospitals as EBOS Invests $9.5MÂ at $0.0575 ...
MELBOURNE, Australia--(BUSINESS WIRE)-- MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, announces a $9.5 million strategic investment by one of Australasia’s leading healthcare companies, EBOS Group. The investment is through a placement of approximately 165m ordinary shares in MedAdvisor at $0.0575 per share. EBOS has also purchased an additional 20 million shares in an off-market transaction. EBOS becomes a substantial shareholder in MedAdvisor with a holding of just over 14%, along...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.